Angelo Gambi

605 total citations
10 papers, 185 citations indexed

About

Angelo Gambi is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Angelo Gambi has authored 10 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Angelo Gambi's work include Breast Cancer Treatment Studies (4 papers), School Health and Nursing Education (2 papers) and Global Cancer Incidence and Screening (2 papers). Angelo Gambi is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), School Health and Nursing Education (2 papers) and Global Cancer Incidence and Screening (2 papers). Angelo Gambi collaborates with scholars based in Italy, Netherlands and United Kingdom. Angelo Gambi's co-authors include Oriana Nanni, Annalisa Volpi, Emanuela Scarpi, Franca Zanetti, A. Bergamaschi, S Stampi, Dino Amadori, Donata Casadei Giunchi, Giovanni William Oliverio and D. Amadori and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and British Journal of Cancer.

In The Last Decade

Angelo Gambi

10 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Gambi Italy 8 107 59 42 37 24 10 185
Kathryn Edmiston United States 9 130 1.2× 61 1.0× 27 0.6× 23 0.6× 6 0.3× 14 280
Madeline Polak United States 9 78 0.7× 26 0.4× 24 0.6× 42 1.1× 6 0.3× 24 225
Lanlan Pang China 11 97 0.9× 31 0.5× 19 0.5× 29 0.8× 6 0.3× 31 282
Jeroen W. G. Derksen Netherlands 8 99 0.9× 21 0.4× 19 0.5× 66 1.8× 3 0.1× 21 182
Marie‐Elise Parent Canada 6 39 0.4× 21 0.4× 7 0.2× 58 1.6× 13 0.5× 7 208
Elaine Kennedy United States 7 66 0.6× 79 1.3× 26 0.6× 3 0.1× 5 0.2× 11 275
Maria do Socorro Maciel Brazil 7 117 1.1× 77 1.3× 49 1.2× 8 0.2× 2 0.1× 11 265
Zhuo Geng United States 6 268 2.5× 12 0.2× 70 1.7× 17 0.5× 9 0.4× 13 387
Reina Sekiya Japan 9 147 1.4× 22 0.4× 7 0.2× 32 0.9× 3 0.1× 16 268
Maruta A. Blatchins United States 6 41 0.4× 35 0.6× 26 0.6× 5 0.1× 3 0.1× 10 228

Countries citing papers authored by Angelo Gambi

Since Specialization
Citations

This map shows the geographic impact of Angelo Gambi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Gambi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Gambi more than expected).

Fields of papers citing papers by Angelo Gambi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Gambi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Gambi. The network helps show where Angelo Gambi may publish in the future.

Co-authorship network of co-authors of Angelo Gambi

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Gambi. A scholar is included among the top collaborators of Angelo Gambi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Gambi. Angelo Gambi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Boccardo, Francesco, Dino Amadori, Pamela Guglielmini, et al.. (2010). Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer. Oncology. 78(3-4). 274–281. 12 indexed citations
2.
Amadori, Dino, Oriana Nanni, Annalisa Volpi, et al.. (2007). Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis. Breast Cancer Research and Treatment. 108(2). 259–264. 9 indexed citations
3.
Capasso, Margherita, Antonio Di Muzio, Manola Comar, et al.. (2006). The association of chronic hepatitis B and myopathy. Neurology. 67(8). 1467–1469. 13 indexed citations
4.
Nanni, Oriana, Annalisa Volpi, Giovanni Luca Frassineti, et al.. (2002). Role of biological markers in the clinical outcome of colon cancer. British Journal of Cancer. 87(8). 868–875. 45 indexed citations
5.
Bergamaschi, A., et al.. (2000). Tobacco Smoking among High School Students in Romagna (Italy) and Evaluation of a Prevention Campaign. Substance Use & Misuse. 35(9). 1277–1295. 8 indexed citations
6.
Amadori, Dino, Oriana Nanni, M. Marangolo, et al.. (2000). Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter Study. Journal of Clinical Oncology. 18(17). 3125–3134. 43 indexed citations
7.
Zanetti, Franca, et al.. (1998). Smoking habits, exposure to passive smoking and attitudes to a non-smoking policy among hospital staff. Public Health. 112(1). 57–62. 36 indexed citations
8.
Amadori, D., Annalisa Volpi, Oriana Nanni, et al.. (1997). Prospective use of tumor proliferative activity for adjuvant therapy in node-negative breast cancer patients. Cell Proliferation. 30. 1 indexed citations
9.
Ferro, Salvatore, et al.. (1996). A Randomized Trial on Breast Self-Examination in Faenza (Northern-Italy). Tumori Journal. 82(4). 329–334. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026